|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wightman B, Ha I and Ruvkun G:
Posttranscriptional regulation of the heterochronic gene lin-14 by
lin-4 mediates temporal pattern formation in C. elegans.
Cell. 75:855–862. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Motoyama K, Inoue H, Takatsuno Y, Tanaka
F, Mimori K, Uetake H, Sugihara K and Mori M: Over- and
under-expressed microRNAs in human colorectal cancer. Int J Oncol.
34:1069–1075. 2009.PubMed/NCBI
|
|
4
|
Du Y, Wang L, Wu H, Zhang Y, Wang K and Wu
D: MicroRNA-141 inhibits migration of gastric cancer by targeting
zinc finger E-box-binding homeobox 2. Mol Med Rep. 12:3416–3422.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kato M, Goto Y, Matsushita R, Kurozumi A,
Fukumoto I, Nishikawa R, Sakamoto S, Enokida H, Nakagawa M,
Ichikawa T, et al: MicroRNA-26a/b directly regulate La-related
protein 1 and inhibit cancer cell invasion in prostate cancer. Int
J Oncol. 47:710–718. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kawano M, Tanaka K, Itonaga I, Ikeda S,
Iwasaki T and Tsumura H: microRNA-93 promotes cell proliferation
via targeting of PTEN in osteosarcoma cells. J Exp Clin Cancer Res.
34:762015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang L-G and Gu J: Serum microRNA-29a is a
promising novel marker for early detection of colorectal liver
metastasis. Cancer Epidemiol. 36:e61–e67. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Shukla K, Sharma AK, Ward A, Will R,
Hielscher T, Balwierz A, Breunig C, Münstermann E, König R,
Keklikoglou I, et al: MicroRNA-30c-2-3p negatively regulates NF-κB
signaling and cell cycle progression through downregulation of
TRADD and CCNE1 in breast cancer. Mol Oncol. 9:1106–1119. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang Y, Zhang X, Li H, Yu J and Ren X: The
role of miRNA-29 family in cancer. Eur J Cell Biol. 92:123–128.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jiang H, Zhang G, Wu JH and Jiang CP:
Diverse roles of miR-29 in cancer (review). Oncol Rep.
31:1509–1516. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang D, Qiu C, Zhang H, Wang J, Cui Q and
Yin Y: Human microRNA oncogenes and tumor suppressors show
significantly different biological patterns: From functions to
targets. PLoS One. 5:e130672010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Esquela-Kerscher A and Slack FJ: Oncomirs
- microRNAs with a role in cancer. Nat Rev Cancer. 6:259–269. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhao Z, Wang L, Song W, Cui H, Chen G,
Qiao F, Hu J, Zhou R and Fan H: Reduced miR-29a-3p expression is
linked to the cell proliferation and cell migration in gastric
cancer. World J Surg Oncol. 13:1012015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhao D, Jiang X, Yao C, Zhang L, Liu H,
Xia H and Wang Y: Heat shock protein 47 regulated by miR-29a to
enhance glioma tumor growth and invasion. J Neurooncol. 118:39–47.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lu L, Xue X, Lan J, Gao Y, Xiong Z, Zhang
H, Jiang W, Song W and Zhi Q: MicroRNA-29a upregulates MMP2 in oral
squamous cell carcinoma to promote cancer invasion and
anti-apoptosis. Biomed Pharmacother. 68:13–19. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yamamoto N, Kinoshita T, Nohata N, Yoshino
H, Itesako T, Fujimura L, Mitsuhashi A, Usui H, Enokida H, Nakagawa
M, et al: Tumor-suppressive microRNA-29a inhibits cancer cell
migration and invasion via targeting HSP47 in cervical squamous
cell carcinoma. Int J Oncol. 43:1855–1863. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhu XC, Dong QZ, Zhang XF, Deng B, Jia HL,
Ye QH, Qin LX and Wu XZ: microRNA-29a suppresses cell proliferation
by targeting SPARC in hepatocellular carcinoma. Int J Mol Med.
30:1321–1326. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Volinia S, Calin GA, Liu CG, Ambs S,
Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, et
al: A microRNA expression signature of human solid tumors defines
cancer gene targets. Proc Natl Acad Sci USA. 103:2257–2261. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yanaihara N, Caplen N, Bowman E, Seike M,
Kumamoto K, Yi M, Stephens RM, Okamoto A, Yokota J, Tanaka T, et
al: Unique microRNA molecular profiles in lung cancer diagnosis and
prognosis. Cancer Cell. 9:189–198. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Han YC, Park CY, Bhagat G, Zhang J, Wang
Y, Fan JB, Liu M, Zou Y, Weissman IL and Gu H: microRNA-29a induces
aberrant self-renewal capacity in hematopoietic progenitors, biased
myeloid development, and acute myeloid leukemia. J Exp Med.
207:475–489. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Santanam U, Zanesi N, Efanov A, Costinean
S, Palamarchuk A, Hagan JP, Volinia S, Alder H, Rassenti L, Kipps
T, et al: Chronic lymphocytic leukemia modeled in mouse by targeted
miR-29 expression. Proc Natl Acad Sci USA. 107:12210–12215. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wu Q, Wang C, Lu Z, Guo L and Ge Q:
Analysis of serum genome-wide microRNAs for breast cancer
detection. Clin Chim Acta. 413:1058–1065. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bandrés E1, Cubedo E, Agirre X, Malumbres
R, Zárate R, Ramirez N, Abajo A, Navarro A, Moreno I, Monzó M, et
al: Identification by Real-time PCR of 13 mature microRNAs
differentially expressed in colorectal cancer and non-tumoral
tissues. Mol Cancer. 5:292006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kara M, Yumrutas O, Ozcan O, Celik OI,
Bozgeyik E, Bozgeyik I and Tasdemir S: Differential expressions of
cancer-associated genes and their regulatory miRNAs in colorectal
carcinoma. Gene. 567:81–86. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tang W, Zhu Y, Gao J, Fu J, Liu C, Liu Y,
Song C, Zhu S, Leng Y, Wang G, et al: MicroRNA-29a promotes
colorectal cancer metastasis by regulating matrix metalloproteinase
2 and E-cadherin via KLF4. Br J Cancer. 110:450–458. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kuo TY, Hsi E, Yang IP, Tsai PC, Wang JY
and Juo SH: Computational analysis of mRNA expression profiles
identifies microRNA-29a/c as predictor of colorectal cancer early
recurrence. PLoS One. 7:e315872012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Weissmann-Brenner A, Kushnir M, Yanai
Lithwick G, Aharonov R, Gibori H, Purim O, Kundel Y, Morgenstern S,
Halperin M, Niv Y, et al: Tumor microRNA-29a expression and the
risk of recurrence in stage II colon cancer. Int J Oncol.
40:2097–2103. 2012.PubMed/NCBI
|
|
28
|
Yi R, Li Y, Wang FL, Miao G, Qi RM and
Zhao YY: MicroRNAs as diagnostic and prognostic biomarkers in
colorectal cancer. World J Gastrointest Oncol. 8:330–340. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chen L, Xiao H, Wang ZH, Huang Y, Liu ZP,
Ren H and Song H: miR-29a suppresses growth and invasion of gastric
cancer cells in vitro by targeting VEGF-A. BMB Rep. 47:39–44. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Goubran HA, Kotb RR, Stakiw J, Emara ME
and Burnouf T: Regulation of tumor growth and metastasis: The role
of tumor microenvironment. Cancer Growth Metastasis. 7:9–18. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chu YW, Yang PC, Yang SC, Shyu YC, Hendrix
MJ, Wu R and Wu CW: Selection of invasive and metastatic
subpopulations from a human lung adenocarcinoma cell line. Am J
Respir Cell Mol Biol. 17:353–360. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Smith JJ, Deane NG, Wu F, Merchant NB,
Zhang B, Jiang A, Lu P, Johnson JC, Schmidt C, Bailey CE, et al:
Experimentally derived metastasis gene expression profile predicts
recurrence and death in patients with colon cancer.
Gastroenterology. 138:958–968. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Alshalalfa M and Alhajj R: Using
context-specific effect of miRNAs to identify functional
associations between miRNAs and gene signatures. BMC
Bioinformatics. 14 Suppl 12:S12013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Li S, Shen L, Sun L, Xu J, Jin P, Chen L
and Ma F: Small RNA-Seq analysis reveals microRNA-regulation of the
Imd pathway during Escherichia coli infection in Drosophila.
Dev Comp Immunol. 70:80–87. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Blencowe B, Brenner S, Hughes T and Morris
Q: Post-transcriptional gene regulation: RNA-protein interactions,
RNA processing, mRNA stability and localization. Pac Symp
Biocomput. 14:545–548. 2009.
|
|
36
|
Selbach M, Schwanhäusser B, Thierfelder N,
Fang Z, Khanin R and Rajewsky N: Widespread changes in protein
synthesis induced by microRNAs. Nature. 455:58–63. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ohta Y, Kousaka K, Nagata-Ohashi K, Ohashi
K, Muramoto A, Shima Y, Niwa R, Uemura T and Mizuno K: Differential
activities, subcellular distribution and tissue expression patterns
of three members of Slingshot family phosphatases that
dephosphorylate cofilin. Genes Cells. 8:811–824. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Brill S, Li S, Lyman CW, Church DM,
Wasmuth JJ, Weissbach L, Bernards A and Snijders AJ: The Ras
GTPase-activating-protein-related human protein IQGAP2 harbors a
potential actin binding domain and interacts with calmodulin and
Rho family GTPases. Mol Cell Biol. 16:4869–4878. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Leung T, Chen XQ, Tan I, Manser E and Lim
L: Myotonic dystrophy kinase-related Cdc42-binding kinase acts as a
Cdc42 effector in promoting cytoskeletal reorganization. Mol Cell
Biol. 18:130–140. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Nakamura N, Oshiro N, Fukata Y, Amano M,
Fukata M, Kuroda S, Matsuura Y, Leung T, Lim L and Kaibuchi K:
Phosphorylation of ERM proteins at filopodia induced by Cdc42.
Genes Cells. 5:571–581. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Kamatani A, Nakagawa Y, Akao Y, Maruyama
N, Nagasaka M, Shibata T, Tahara T and Hirata I: Downregulation of
anti-oncomirs miR-143/145 cluster occurs before APC gene aberration
in the development of colorectal tumors. Med Mol Morphol.
46:166–171. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Slaby O, Svoboda M, Fabian P, Smerdova T,
Knoflickova D, Bednarikova M, Nenutil R and Vyzula R: Altered
expression of miR-21, miR-31, miR-143 and miR-145 is related to
clinicopathologic features of colorectal cancer. Oncology.
72:397–402. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Akao Y, Nakagawa Y and Naoe T: MicroRNAs
143 and 145 are possible common onco-microRNAs in human cancers.
Oncol Rep. 16:845–850. 2006.PubMed/NCBI
|
|
44
|
Arndt GM1, Dossey L, Cullen LM, Lai A,
Druker R, Eisbacher M, Zhang C, Tran N, Fan H, Retzlaff K, et al:
Characterization of global microRNA expression reveals oncogenic
potential of miR-145 in metastatic colorectal cancer. BMC Cancer.
9:3742009. View Article : Google Scholar : PubMed/NCBI
|
